Next |
home / stock / gthx / gthx message board
Subject | By | Source | When |
---|---|---|---|
Thinking through this more- arent most CRC tumors | sks144 | investorshub | 02/28/2023 1:44:07 AM |
Agreed! Lets see how much cash they have | stocksrising | investorshub | 02/16/2023 1:42:45 AM |
I hope they survive. Drug has real potential | sks144 | investorshub | 02/15/2023 5:59:20 PM |
Lets see how much cash they have after | stocksrising | investorshub | 02/13/2023 7:36:32 PM |
What? Oh my!!! lolzzzzzzz | SurgeGuy2.0 | investorshub | 11/01/2021 9:44:43 PM |
GEEZE..WHY DID ALL THE NEWBIES LEAVE? HEE!-HAW! | SurgeGuy2.0 | investorshub | 10/13/2021 2:25:03 PM |
NO one cares!!! lolzzzzzzzzzzz, SCAM!!!!! | SurgeGuy2.0 | investorshub | 10/04/2021 2:12:32 PM |
October 01 2021 - 07:45AM | bUrRpPPP! | investorshub | 10/01/2021 11:52:16 AM |
No one gives a chit about this SCAM! lolzzzzzzzzzzzzzzzzz | SurgeGuy2.0 | investorshub | 09/30/2021 10:13:59 PM |
$GTHX JPMorgan cautions that G1's lead asset Cosela--aimed | bUrRpPPP! | investorshub | 09/30/2021 7:02:12 PM |
Im long on GTHX, this stock is going | Ganz | investorshub | 09/13/2021 4:59:35 PM |
It's funny with biopharmas - I've seen them | jerseyboy | investorshub | 02/13/2021 3:21:15 AM |
price target avg $50 & max $82 as | trade-stock000 | investorshub | 02/13/2021 2:15:27 AM |
GTHX Webcast and Conference Call | trade-stock000 | investorshub | 02/13/2021 2:04:10 AM |
congrats(: what's your price target expectation on Tuesday? | trade-stock000 | investorshub | 02/13/2021 12:25:41 AM |
YESSSSS!! I made a big bet on this | jerseyboy | investorshub | 02/13/2021 12:06:44 AM |
GTHX FDA APPROVAL - Today After Hrs(:-LINK | trade-stock000 | investorshub | 02/12/2021 10:52:36 PM |
I found an interesting comment from poster Alex | MDEM | investorshub | 02/12/2021 2:14:58 PM |
Steadily up goes the share price, probably at | jerseyboy | investorshub | 02/03/2021 11:28:07 PM |
My plan is to sell half in week | Pendle Witch | investorshub | 02/02/2021 4:48:15 PM |
News, Short Squeeze, Breakout and More Instantly...
G1 Therapeutics, Inc. (NASDAQ:GTHX) shares are trading higher Thursday amid M&A blog speculation of a takeover offer. What To Know: Accor...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
- Achieved $14.1 Million in Net Revenue from Sales of COSELA® (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib in Combination with a TROP2 Antibod...